EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling
Authors:
Open Access
- 28 March 2016
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 48 (6) , 2580-2590
Abstract
There are no effective therapies for advanced renal cell carcinoma (RCC), except for VEGFR inhibitors with only ~50% response rate. To identify novel targets and biomarkers for RCC is of great importance in treating RCC. In this study, we observed that eukaryotic initiation factor 3d (EIF3D) expression was significantly increased in RCC compared with paracarcinoma tissue using immunohistochemistry staining and western blot analysis. Furthermore, bioinformatics meta-analysis using ONCOMINE microarray datasets showed that EIF3D mRNA expressions in CCRCC tissue specimens were significantly higher than that in normal tissue specimens. In addition, RCC tissue microarray demonstrated that elevated EIF3D expression was positively correlated with TNM stage and tumor size. EIF3D silencing in human 786-O and ACHN CCRCC cell lines by RNA interference demonstrated that EIF3D knockdown obviously inhibited cell proliferation and colony formation, caused G2/M arrest through downregulation of Cyclin B1 and Cdk1 and upregulation of p21, and induced apoptosis shown by sub-G1 accumulation and RARP cleavage. Moreover, correlation analysis using ONCOMINE microarray datasets indicated that increased EIF3D mRNA expression was positively correlated to PCNA, Cyclin B1 and CDK1 mRNA expression in RCC. Collectively, these results provide reasonable evidences that EIF3D may function as a potential proto-oncogene that participates in the occurrence and progression of RCC.Keywords
This publication has 25 references indexed in Scilit:
- eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translationOncotarget, 2015
- The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancerMedical Oncology, 2015
- Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancerMedical Oncology, 2015
- RNAi‐Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG CellsChemical Biology & Drug Design, 2015
- Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cellsBioscience Reports, 2014
- Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinomaCanadian Urological Association Journal, 2014
- Eukaryotic translation initiation factors in cancer development and progressionCancer Letters, 2013
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell CarcinomasClinical Cancer Research, 2008
- New Anti-Angiogenic Targeted Therapy in Advanced Renal Cell Carcinoma (RCC):Current Status and Future ProspectsReviews on Recent Clinical Trials, 2008